HOXB7 and glioblastoma: Figures 3A,B shows that in both all grade and LGG, patients in the low HOXB7 expression group achieve a significantly longer survival time than their high expression counterparts (p < 0.0001, p = 0.0047, respectively). However, this association was not reproduced in conventional statistical significance in Grade IV (GBM) group (p = 0.0535, Figure 3C). Furthermore, the above results were also confirmed in the patients from the Ditan Hospital database (Figures 3D–F).